1. Home
  2. CTNT vs PRFX Comparison

CTNT vs PRFX Comparison

Compare CTNT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

SELL

Current Price

$3.22

Market Cap

3.5M

Sector

N/A

ML Signal

SELL

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.82

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
PRFX
Founded
2016
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
CTNT
PRFX
Price
$3.22
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 32.7M
232.6K
Earning Date
11-06-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.74
N/A
EPS
N/A
★ N/A
Revenue
★ $1,288,536.00
N/A
Revenue This Year
$78.50
N/A
Revenue Next Year
$52.17
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 182.69
N/A
52 Week Low
$0.03
$0.58
52 Week High
$2,120.00
$5.39

Technical Indicators

Market Signals
Indicator
CTNT
PRFX
Relative Strength Index (RSI) 60.01 39.06
Support Level $2.95 $0.58
Resistance Level $4.18 $1.28
Average True Range (ATR) 0.34 0.04
MACD 0.19 -0.01
Stochastic Oscillator 72.83 17.18

Price Performance

Historical Comparison
CTNT
PRFX

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: